Jinyu Bio-Technology Co Ltd (600201) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Jinyu Bio-Technology Co Ltd (600201) has a cash flow conversion efficiency ratio of 0.018x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥102.68 Million ≈ $15.03 Million USD) by net assets (CN¥5.65 Billion ≈ $827.18 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jinyu Bio-Technology Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how Jinyu Bio-Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read total liabilities of Jinyu Bio-Technology Co Ltd for a breakdown of total debt and financial obligations.
Jinyu Bio-Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jinyu Bio-Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TIZA Information Industry Corporation Inc
SHE:300209
|
-0.014x |
|
Distribuidora Internacional de Alimentación S.A
MC:DIA
|
1.808x |
|
OliX PharmaceuticalsInc
KQ:226950
|
0.023x |
|
Hanon Systems
KO:018880
|
0.023x |
|
DL E&C Co Ltd
KO:375500
|
0.015x |
|
Krungthai Card PCL
BK:KTC
|
0.058x |
|
Krungthai Card Public Company Limited
BK:KTC-R
|
-0.012x |
|
BBB Foods Inc.
NYSE:TBBB
|
0.266x |
Annual Cash Flow Conversion Efficiency for Jinyu Bio-Technology Co Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of Jinyu Bio-Technology Co Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see 600201 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥5.42 Billion ≈ $792.44 Million |
CN¥289.55 Million ≈ $42.37 Million |
0.053x | -27.11% |
| 2023-12-31 | CN¥5.65 Billion ≈ $827.50 Million |
CN¥414.83 Million ≈ $60.70 Million |
0.073x | +13.87% |
| 2022-12-31 | CN¥5.35 Billion ≈ $782.82 Million |
CN¥344.65 Million ≈ $50.43 Million |
0.064x | -32.80% |
| 2021-12-31 | CN¥5.56 Billion ≈ $813.64 Million |
CN¥533.08 Million ≈ $78.01 Million |
0.096x | -27.88% |
| 2020-12-31 | CN¥5.26 Billion ≈ $770.13 Million |
CN¥699.61 Million ≈ $102.38 Million |
0.133x | +59.72% |
| 2019-12-31 | CN¥4.87 Billion ≈ $712.50 Million |
CN¥405.24 Million ≈ $59.30 Million |
0.083x | +2.89% |
| 2018-12-31 | CN¥5.22 Billion ≈ $764.23 Million |
CN¥422.46 Million ≈ $61.82 Million |
0.081x | -59.37% |
| 2017-12-31 | CN¥4.48 Billion ≈ $655.26 Million |
CN¥891.44 Million ≈ $130.45 Million |
0.199x | -1.20% |
| 2016-12-31 | CN¥3.75 Billion ≈ $549.13 Million |
CN¥756.12 Million ≈ $110.64 Million |
0.201x | -15.68% |
| 2015-12-31 | CN¥2.07 Billion ≈ $302.70 Million |
CN¥494.32 Million ≈ $72.33 Million |
0.239x | -33.42% |
| 2014-12-31 | CN¥1.63 Billion ≈ $238.59 Million |
CN¥585.19 Million ≈ $85.63 Million |
0.359x | -29.15% |
| 2013-12-31 | CN¥1.28 Billion ≈ $187.57 Million |
CN¥649.34 Million ≈ $95.02 Million |
0.507x | +430.26% |
| 2012-12-31 | CN¥1.08 Billion ≈ $157.69 Million |
CN¥102.95 Million ≈ $15.06 Million |
0.096x | -48.88% |
| 2011-12-31 | CN¥991.13 Million ≈ $145.03 Million |
CN¥185.20 Million ≈ $27.10 Million |
0.187x | +264.74% |
| 2010-12-31 | CN¥844.15 Million ≈ $123.53 Million |
CN¥-95.75 Million ≈ $-14.01 Million |
-0.113x | -247.73% |
| 2009-12-31 | CN¥750.98 Million ≈ $109.89 Million |
CN¥-24.50 Million ≈ $-3.58 Million |
-0.033x | -110.54% |
| 2008-12-31 | CN¥723.47 Million ≈ $105.87 Million |
CN¥223.91 Million ≈ $32.77 Million |
0.309x | +61.13% |
| 2007-12-31 | CN¥708.54 Million ≈ $103.68 Million |
CN¥136.09 Million ≈ $19.91 Million |
0.192x | +13.34% |
| 2006-12-31 | CN¥605.80 Million ≈ $88.65 Million |
CN¥102.66 Million ≈ $15.02 Million |
0.169x | +245.73% |
| 2005-12-31 | CN¥577.16 Million ≈ $84.46 Million |
CN¥28.29 Million ≈ $4.14 Million |
0.049x | -63.17% |
| 2004-12-31 | CN¥609.02 Million ≈ $89.12 Million |
CN¥81.06 Million ≈ $11.86 Million |
0.133x | +249.67% |
| 2003-12-31 | CN¥573.94 Million ≈ $83.99 Million |
CN¥-51.04 Million ≈ $-7.47 Million |
-0.089x | -149.42% |
| 2002-12-31 | CN¥529.82 Million ≈ $77.53 Million |
CN¥95.34 Million ≈ $13.95 Million |
0.180x | +369.42% |
| 2001-12-31 | CN¥517.19 Million ≈ $75.68 Million |
CN¥-34.55 Million ≈ $-5.06 Million |
-0.067x | -123.55% |
| 2000-12-31 | CN¥344.80 Million ≈ $50.45 Million |
CN¥97.80 Million ≈ $14.31 Million |
0.284x | +410.31% |
| 1999-12-31 | CN¥334.58 Million ≈ $48.96 Million |
CN¥-30.58 Million ≈ $-4.48 Million |
-0.091x | +14.83% |
| 1998-12-31 | CN¥333.06 Million ≈ $48.74 Million |
CN¥-35.74 Million ≈ $-5.23 Million |
-0.107x | -- |
About Jinyu Bio-Technology Co Ltd
Jinyu Bio-technology Co., Ltd. manufacturing and sales of veterinary biological drugs in China. The company operates through three segments, such as veterinary biological products, veterinary chemical drugs, and traditional Chinese veterinary medicines. The company offers various pig vaccines, including combined porcine circovirus type 2 and mycoplasma pneumoniae, classical swine fever, combined … Read more